ITCN20090008A1 - Composizione di acido butirrico miscelato con probiotici e prebiotici - Google Patents
Composizione di acido butirrico miscelato con probiotici e prebiotici Download PDFInfo
- Publication number
- ITCN20090008A1 ITCN20090008A1 IT000008A ITCN20090008A ITCN20090008A1 IT CN20090008 A1 ITCN20090008 A1 IT CN20090008A1 IT 000008 A IT000008 A IT 000008A IT CN20090008 A ITCN20090008 A IT CN20090008A IT CN20090008 A1 ITCN20090008 A1 IT CN20090008A1
- Authority
- IT
- Italy
- Prior art keywords
- association
- ability
- butyric acid
- intestine
- prebiotics
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims description 12
- 235000013406 prebiotics Nutrition 0.000 title claims description 10
- 239000006041 probiotic Substances 0.000 title claims description 8
- 235000018291 probiotics Nutrition 0.000 title claims description 8
- 239000002253 acid Substances 0.000 title 1
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical group CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 claims description 18
- 239000004615 ingredient Substances 0.000 claims description 7
- 210000000936 intestine Anatomy 0.000 claims description 5
- 230000000529 probiotic effect Effects 0.000 claims description 5
- 235000016709 nutrition Nutrition 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 235000013305 food Nutrition 0.000 claims description 2
- 229910017053 inorganic salt Inorganic materials 0.000 claims description 2
- 210000002429 large intestine Anatomy 0.000 claims description 2
- 238000010521 absorption reaction Methods 0.000 claims 1
- 210000000987 immune system Anatomy 0.000 claims 1
- 210000004347 intestinal mucosa Anatomy 0.000 claims 1
- 235000015097 nutrients Nutrition 0.000 claims 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 4
- 238000003908 quality control method Methods 0.000 description 4
- 229920001800 Shellac Polymers 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 229940113147 shellac Drugs 0.000 description 3
- 239000004208 shellac Substances 0.000 description 3
- ZLGIYFNHBLSMPS-ATJNOEHPSA-N shellac Chemical compound OCCCCCC(O)C(O)CCCCCCCC(O)=O.C1C23[C@H](C(O)=O)CCC2[C@](C)(CO)[C@@H]1C(C(O)=O)=C[C@@H]3O ZLGIYFNHBLSMPS-ATJNOEHPSA-N 0.000 description 3
- 235000013874 shellac Nutrition 0.000 description 3
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 2
- 229920000881 Modified starch Polymers 0.000 description 2
- 239000004368 Modified starch Substances 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 2
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 2
- 239000008108 microcrystalline cellulose Substances 0.000 description 2
- 229940016286 microcrystalline cellulose Drugs 0.000 description 2
- 235000019426 modified starch Nutrition 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- 239000004408 titanium dioxide Substances 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 240000002853 Nelumbo nucifera Species 0.000 description 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- FYPVXEILSNEKOO-UHFFFAOYSA-L calcium;butanoate Chemical compound [Ca+2].CCCC([O-])=O.CCCC([O-])=O FYPVXEILSNEKOO-UHFFFAOYSA-L 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 238000011981 development test Methods 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 238000001033 granulometry Methods 0.000 description 1
- 230000008821 health effect Effects 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000011265 semifinished product Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
- A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
- A23L29/244—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin from corms, tubers or roots, e.g. glucomannan
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7016—Disaccharides, e.g. lactose, lactulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Nutrition Science (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Molecular Biology (AREA)
- Mycology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dispersion Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicinal Preparation (AREA)
Description
TITOLO COMPOSIZIONE Dì ACIDO BUTIRRICO MISCELATO CON PROBIOTICI E PREBIOTICI
Descrizione :
La presente invenzione si pone nel campo delia tecnica dì produzione dei prodotti alimentari e/o salutistici Attualmente non ci sono ancora sul mercato associazioni di questi tipi di ingredienti (Prebiotico, Probiotico, Acido butirrico e/o suo sale organico e/o inorganico). Sul mercato esistono attualmente in commercio prodotti alimentari salutistici che presentano tali ingredienti solo da soli o in associazioni di Acido butirrico e priebiotico, ma la vera novità à ̈ T'associazione dell'acido butirrico col simbiotico ( miscela di prebiotico e probiotico) che à ̈ la più efficace perché completa dal punto d vista nutritivo a svolgere un’azione salutistica e nutritiva a livello deli’ intestino in generale e del grosso intestino in particolare .
Nella presente invenzione infatti si à ̈ provveduto, attraverso molteplici prove di messa a punto, a riunire in una compressa a rilascio modificato un prebiotico costituito da una fibra alimentare e un probiotico costituito da fermenti lattici vivi e l'acido butirrico o un suo sale e a fare si che l’associazione dei componenti potesse attraversare la barriera gastrica e giungere all’intestino in loto dove poter svolgere la sua azione salutistica.
Composizione tipo :
Cellulosa microcristallina 0,3118980 Dosaggio ingredienti attivi Calcio butirrato 0,3070000 250mg di Ac butirrico Prebiotico 0,1000000 100 mg
Fermento lattico 0,01100 1,02 MLD
Magnesio sterrato 0,0100000
Gomma lacca 0,0100000
PVP 30 0,0050000
Acido citrico 0,0050000
HPMC alta densità 0,1890000
Colorante 0,0000020
Amido modificato 0,0150000
Talco, titanio biossido 0,0150000
In grassetto sono evidenziati gli ingredienti della associazione con indicati i dosaggi tipici della associazione, questi dosaggi possono comunque essere variati sia in aumento che in diminuzione in percentuali variabili da 0 a 300 %. Il problema tecnico à ̈ di far passare la barriera gastrica a tutti e tre gli ingredienti in modo da arrivare nel intestino e nel colon in particolare integri e attivi.
Descrizione di una produzione tipica con soluzione del problema tecnico :
Oli ingredienti previsti dalla soprastante tabella vengono pesati separatamente
1. In un miscelatore per polveri vengono miscelati i seguenti ingredienti precedentemente pesati { Calcio bulinato, Prebiotico, Fermento lattico, PVP30,HPMC alta densità , Cellulosa microcristallina) per almeno 15 minuti
2. Alla miscela così fatta viene aggiunto il magnesio stearato e si continua la miscelazione per altri 5 minuti circa.
3. Si porta un campione della miscela cosi fatta al controllo qualità per le verifiche previste dalla farmacopea per le miscela di poveri { granulometria, omogeneità della miscela, peso specifico apparente, umidità )
4. Utilizzando una comprimitrice opportuna si allestiscono le compresse che andranno a costituire il nucleo del prodotto finito (per questa ricetta tipo il nucleo à ̈ di 935 mg).
5. I nuclei vengono raccolti in appositi contenitori e un campione viene portato al controllo qualità per le verifiche previste dalla farmacopea per le compresse (uniformità di massa [± 5%], carico di rottura [98 Newton ± 3%], umidità [< 8 %], dimensioni [spessore max 7 mm lunghezza 19 mm larghezza 10 mm], friabilità perdita [max I %}, disgregazione [non meno di 9 h a ph > 6.5]) in [] i valori di riferimento
6. Si attende liberazione semilavorato dal controllo qualitÃ
7. SÌ prepara la miscela di filmatura enterica si pesa la gomma lacca e si scioglie in etanolo assoluto, quindi sì spruzza sulle compresse
8. Si spruzza la gomma lacca fino a che il peso medio delle compresse à ̈ aumentato di quanto previsto dalla ricetta ( in questo caso peso medio nucleo 10 mg )
9. Si prepara la miscela di filmatura finale pesando l’Amido modificato, il titanio biossido, il talco, il colorante e l'acido citrico e sciogliendo il tutto in acqua
10. Si spruzza sulla compressa rivestita fino al peso finale.
11. Si porta al controllo qualità per verifiche finali ( Uniformità di peso [960 mg ± 3 %],
Disgregazione [> 10 h], conta microbiologica totale [>100 ufc/g, lieviti e muffe >10fc/g, salmonelle assenti in 10 g, patogeni assenti])
12. Confezionamento finale in blister o pilloliera
Claims (1)
- TITOLO COMPOSIZIONE DI ACIDO BUTIRRICO MISCELATO CON PROBIOTICI E PREBIOTICI RIVENDICAZIONI La presente invenzione RIVENDICA : J ) nel campo della produzione dei prodotti alimentari e/o salutistici P'associazione di questi tipi di ingredienti in qualunque dosaggio Prebiotico, Probiotico, Acido butirrico e/o suo sale organico e/o inorganico, 2) Γ associazione dell’acido butirrico col simbiotico ( miscela di prebiotico e probiotico) che à ̈ la più efficace perché completa dal punto di vista nutritivo a svolgere un’azione salutistica e nutritiva a livello dell ’intestino in generale e del grosso intestino in particolare . 3) La capacità dell’associazione di migliorare l’assorbimento dei nutrienti 4) La capacità dell'associazione di promuovere un corretto funzionamento del sistema immunitario 5) La capacità della associazione di mantenere Γ integrità funzionale e strutturale della mucosa intestinale 6} La capacità della associazione di promuovere la crescita selettiva dei fermenti saprofiti nell’ intestino.
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITCN2009A000008A IT1395328B1 (it) | 2009-08-26 | 2009-08-26 | Composizione di acido butirrico miscelato con probiotici e prebiotici |
ES10171504T ES2411687T3 (es) | 2009-08-26 | 2010-07-30 | Composición nutricional y complemento alimentario que contiene dicha composición nutricional |
EP10171504A EP2289505B1 (en) | 2009-08-26 | 2010-07-30 | Nutritional composition and food supplement containing such a nutritional composition. |
PT101715043T PT2289505E (pt) | 2009-08-26 | 2010-07-30 | Composição nutricional e suplemento alimentar contendo essa composição nutricional |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITCN2009A000008A IT1395328B1 (it) | 2009-08-26 | 2009-08-26 | Composizione di acido butirrico miscelato con probiotici e prebiotici |
Publications (2)
Publication Number | Publication Date |
---|---|
ITCN20090008A1 true ITCN20090008A1 (it) | 2011-02-27 |
IT1395328B1 IT1395328B1 (it) | 2012-09-14 |
Family
ID=41683333
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ITCN2009A000008A IT1395328B1 (it) | 2009-08-26 | 2009-08-26 | Composizione di acido butirrico miscelato con probiotici e prebiotici |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP2289505B1 (it) |
ES (1) | ES2411687T3 (it) |
IT (1) | IT1395328B1 (it) |
PT (1) | PT2289505E (it) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EA027042B1 (ru) | 2011-03-15 | 2017-06-30 | Компани Жервэ Данон | Пластиковая фланцевая емкость и упаковка для пищевых продуктов, содержащая такие емкости |
NL2009744C2 (en) * | 2012-11-02 | 2014-05-06 | Palital Gmbh & Co Kg | New method to compose and process an animal feed additive with butyrate. |
US10206884B2 (en) | 2013-12-20 | 2019-02-19 | Fresenius Kabi Deutschland Gmbh | Microcapsules with polymeric coating comprising a lipid and an active agent |
US10034937B2 (en) | 2015-12-04 | 2018-07-31 | Mead Johnson Nutrition Company | Synergistic nutritional compositions and uses thereof |
AU2016351455B2 (en) * | 2015-11-09 | 2020-08-20 | Mjn U.S. Holdings Llc | Nutritional compositions comprising Lactobacillus rhamnosus GG, as well as dietary butyrate and/or a compound for stimulating formation of endogenous butyrate |
ITUB20159138A1 (it) * | 2015-12-22 | 2017-06-22 | Euro Pharma Srl | Formulazioni terapeutiche integrative per la somministrazione separata, sequenziale o simultanea di acido butirrico, G.S.E probiotici e prebiotici. |
EP3426269A4 (en) | 2016-03-11 | 2019-10-16 | Evolve Biosystems Inc. | FOOD COMPOSITIONS FOR DEHUMIDIFICATION |
PL236296B1 (pl) * | 2017-08-25 | 2020-12-28 | Przed Produkcji Farmaceutycznej Hasco Lek Spolka Akcyjna | Tabletka zawierająca maślan sodu i sposób jej wytwarzania |
IT201800005908A1 (it) * | 2018-05-31 | 2019-12-01 | Compressa gastroresistente rivestita con film per il rilascio protratto di acido butirrico | |
IT202200013138A1 (it) | 2022-06-22 | 2023-12-22 | Cerbios Pharma Sa | Probiotico per l’uso nel trattamento di alterazioni infiammatorie della mucosa intestinale, in particolare obesità |
BE1031379B1 (nl) * | 2023-08-28 | 2024-09-18 | Hipeva | Synergistische samenstelling omvattende boterzuur en agave-fructaan |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004026316A1 (en) * | 2002-09-17 | 2004-04-01 | Danisco A/S | Novel use of carbohydrates and compositions |
DE10244359A1 (de) * | 2002-09-24 | 2004-04-08 | Nutrinova Nutrition Specialties & Food Ingredients Gmbh | Futtermittelzusatz enthaltend mindestens eine Säure und/oder deren Salze, mindestens eine resistente Stärke sowie mindestens ein Polyphenol |
JP2007131541A (ja) * | 2005-11-08 | 2007-05-31 | Kao Corp | 成長ホルモン分泌促進剤 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6426099B1 (en) | 1997-12-03 | 2002-07-30 | Renew Life, Inc. | Herbal formulation for rebuilding intestinal bacteria |
AU5124600A (en) | 1999-04-26 | 2000-11-10 | Imperial Sensus, L.L.C. | Granular delivery system |
ITMI20040187A1 (it) | 2004-02-06 | 2004-05-06 | Cosmo Spa | Composizioni farmaceutiche o dietetiche a base di acidi grassi a catena corta e zuccheri complessi per le disfunzioni intestinali |
GB2466041A (en) | 2008-12-09 | 2010-06-16 | Sanluc Internat Nv | Coated granules comprising butyrate salt |
-
2009
- 2009-08-26 IT ITCN2009A000008A patent/IT1395328B1/it active
-
2010
- 2010-07-30 ES ES10171504T patent/ES2411687T3/es active Active
- 2010-07-30 PT PT101715043T patent/PT2289505E/pt unknown
- 2010-07-30 EP EP10171504A patent/EP2289505B1/en not_active Revoked
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004026316A1 (en) * | 2002-09-17 | 2004-04-01 | Danisco A/S | Novel use of carbohydrates and compositions |
DE10244359A1 (de) * | 2002-09-24 | 2004-04-08 | Nutrinova Nutrition Specialties & Food Ingredients Gmbh | Futtermittelzusatz enthaltend mindestens eine Säure und/oder deren Salze, mindestens eine resistente Stärke sowie mindestens ein Polyphenol |
JP2007131541A (ja) * | 2005-11-08 | 2007-05-31 | Kao Corp | 成長ホルモン分泌促進剤 |
Non-Patent Citations (4)
Title |
---|
FRANCESCHI FRANCESCO ET AL: "Role of probiotics in patients with Helicobacter pylori infection", HELICOBACTER, vol. 12, no. Suppl. 2, November 2007 (2007-11-01), pages 59 - 63, XP002571863, ISSN: 1083-4389 * |
NILSSON ULF ET AL: "Bifidobacterium lactis Bb-12 and Lactobacillus salivarius UCC500 modify carboxylic acid formation in the hindgut of rats given pectin, inulin, and lactitol", JOURNAL OF NUTRITION, vol. 136, no. 8, August 2006 (2006-08-01), pages 2175 - 2180, XP008119610, ISSN: 0022-3166 * |
STROWSKI M Z ET AL: "Probiotic carbohydrates reduce intestinal permeability and inflammation in metabolic diseases", GUT 2009 BMJ PUBLISHING GROUP GBR, vol. 58, no. 8, August 2009 (2009-08-01), pages 1044 - 1045, XP008119617 * |
WILLIAMS L ET AL: "Dietary fiber and other alternative therapies and irritable bowel syndrome", TOPICS IN CLINICAL NUTRITION 2009 LIPPINCOTT WILLIAMS AND WILKINS USA, vol. 24, no. 3, July 2009 (2009-07-01), pages 262 - 271, XP002571864, ISSN: 0883-5691 * |
Also Published As
Publication number | Publication date |
---|---|
EP2289505A1 (en) | 2011-03-02 |
ES2411687T3 (es) | 2013-07-08 |
EP2289505B1 (en) | 2013-03-06 |
IT1395328B1 (it) | 2012-09-14 |
PT2289505E (pt) | 2013-06-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ITCN20090008A1 (it) | Composizione di acido butirrico miscelato con probiotici e prebiotici | |
CN104288120B (zh) | 肠溶植物纤维素硬空心胶囊及其制备方法 | |
CN103301086B (zh) | 一种植物纤维素硬空心胶囊的制备方法 | |
AU2014291777B2 (en) | A composition having a prebiotic effect | |
WO2013171697A1 (en) | Oral composition comprising a low- availability active ingredient, for use as a medicament or a dietary/supplement/nutraceutical | |
MX2012006851A (es) | Granulos para preparaciones farmceuticas, metodos y aparatos para su produccion. | |
CA3161418C (en) | Multi-strain probiotic composition and its use | |
Rashed et al. | Manipulation of gut microbiota as a key target for crohn's disease | |
CN102631331A (zh) | 奥氮平口腔崩解片制剂及其制备方法 | |
CA2806823A1 (en) | Use of a mixture of probiotic bacteria in a mixture with short - chain fatty acids | |
Sharada et al. | Sustained release matrix tablets of indomethacin using hibiscus rosa-sinensis as release retardant | |
ITMI20110934A1 (it) | Tannato di gelatina e sue associazioni per uso nel trattamento di malattie infiammatorie gastrointestinali | |
Ratnaparkhi | Formulation and development of floating drug delivery of Itopride Hcl | |
CN104906067A (zh) | 一种稳定的叶酸包合物的亚铁组合物及其制备方法与制剂 | |
CN103919761B (zh) | 一种苯丙氨酸鳌合钙粉及加工方法 | |
Iswandana et al. | Formulation of various polysaccharides-based multicoated tablets containing dexamethasone and probiotics for inflammatory bowel disease | |
Sousa et al. | MAFLD under the lens: the role of gut microbiota | |
CN104666264B (zh) | 一种盐酸氨基葡萄糖咀嚼片及其制备方法 | |
Ghosh et al. | Probiotic-assisted colon-specific delivery of diclofenac sodium from guar gum matrix tablets: In vitro evaluation | |
Jackson et al. | Ternary blends of some hydrophilic and hydrophobic polymers in colon targeted delivery of diethylcarbamazine | |
Prajapati et al. | Sustained release itopride hydrochloride matrix tablet | |
Kotadiya et al. | In vitro In vivo evaluation of Okragum: guargum compression coated Diclofenac sodium tablets for colonic delivery: a factorial approach | |
US20230124503A1 (en) | Ginsenoside compositions | |
Gupta et al. | Formulation and Evaluation of Orodispersible Tablets of Salbutamol Sulphate | |
IT202100011798A1 (it) | Processo per aumentare la bioaccessibilità intestinale dei polifenoli in un liofilizzato di una matrice vegetale ad alto contenuto di polifenoli |